CSIMarket


Dyadic International Inc  (DYAI)
Other Ticker:  
 


 

Dyadic International Inc

DYAI's Financial Statements and Analysis



Dyadic International Inc increased third quarter of 2023 net loss per share of $-0.06 compare to net loss per share of $-0.06 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.07 realized in previous quarter.


third quarter of 2023
Earnings Per Share Revenues
$ -0.06 $  0 Mill
Unch.     Unch.     -54.86 %



Dyadic International Inc's Revenue fell by -54.86 % in third quarter of 2023 (Sep 30 2023) year on year, to $0 million and declined by -52.57 % sequentially.


Dyadic International Inc is

More on DYAI's Income Statement



Dyadic International Inc's in thethird quarter of 2023 recorded net loss of $-1.614 million, an improvement compare to net loss of $-1.809 million in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-2.153 million realized in previous quarter.

More on DYAI's Growth

Dyadic International Inc Inventories
DYAI's Cash flow In the third quarter of 2023 company's net cash flow was $2 million


Dyadic International Inc does not pay out common stock dividend.

In trailing twelve-month period Dyadic International Inc payed $ -0.26 cash per share, on a free-cash flow basis .

Book value fell by -14.83 % sequentially to $0.27 per share.
Tangible Book value fell to $ 0.27 per share from $ 0.31.

Company repurchased 0.00 million shares or 0.00 % in Sep 30 2023.


More on DYAI's Dividends

 Market Capitalization (Millions) 46
 Shares Outstanding (Millions) 29
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -645
 Net Income (TTM) (Millions $) 2,482
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 84




Dyadic International Inc does not pay out common stock dividend.

In trailing twelve-month period Dyadic International Inc had negative $ -0.26 cash flow per share, on a free-cash flow basis .

Book value fell by -14.83 % sequentially to $0.27 per share.
Tangible Book value fell to $ 0.27 per share from $ 0.31.

Company repurchased 0.00 million shares or 0.00 % in Sep 30 2023.


More on DYAI's Balance Sheets

 Market Capitalization (Millions) 46
 Shares Outstanding (Millions) 29
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -645
 Net Income (TTM) (Millions $) 2,482
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 84
   


  News about Dyadic International Inc Earnings

Dyadic International Inc. Experiences Sharp Contraction in Financial Performance as of Sep 30, 2023



Dyadic International Inc, a prominent company in the biotech industry, recently released its financial results for the fiscal period ending September 30, 2023. These results indicate a mixed bag, with some positive signs of improvement and worrisome declines. As investors scrutinize these figures, considering both short-term and long-term implications, it becomes essential to analyze the impact these results may have on Dyadic International Inc's future.
Revenue Decline:
One of the most significant causes for concern is the sharp decline in revenue. Compared to the similar quarter a year ago, Dyadic experienced a significant drop of -54.859%, equating to $0.40 million in revenue. Moreover, ...

Dyadic International Inc. Makes Heads Turn with Remarkable Revenue Surge, Topping Charts in June 2023



Dyadic International Inc, a biotechnology and pharmaceuticals company, recently announced a significant surge in revenue compared to the previous year's reporting period. Despite this positive development, the company experienced a loss of $0.07 per share in the same fiscal period. While other entities in the biotech and pharmaceutical industries face declining transactions and fading revenue, Dyadic International Inc is showing some resilience. Let's delve into the interesting facts surrounding this development.
Revenue Growth and Losses:
In the most recent fiscal period, Dyadic International Inc witnessed a notable increase in revenue, growing by 27.121% to $0.84 million compared to the c...

Dyadic International Inc's First Quarter of 2023 Reveals Unexpected and Shocking Revenue Plunge

Dyadic International Inc, a biotechnology company, recently reported its earnings for the January to March 31, 2023 period. The company?s net loss was $-0.956 million, a far cry from the deficit of $-2,491.665 million reported for the corresponding period a year ago. Although the company still recorded a loss, it was an improvement from the previous year.
The company?s losses have decreased from $-0.09 per share to $-0.03 per share year-over-year. The income per share also suffered, falling from $87.11 per share in the previous reporting period. The revenue dropped by an alarming -99.849% to $0.98 million, which is a far cry from the $648.43 million recorded in the corresponding reporting period last yea...


Date modified: 2023-11-09T22:02:23+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com